Sensitization to Common Allergens in Adults with Asthma

References

1. ↵
   Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832–6.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Global strategy for asthma management and prevention. Updated from: NHLBI/WHO Workshop Report, 1995. Revised 2002. National Institutes of Health Publication No. 02-3659, 2002.
3. ↵
   Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999; 54: 268–72.

   OpenUrlFREE Full Text
4. ↵
   Soriano JB, Anto JM, Sunyer J, et al. Risk of asthma in the general Spanish population attributable to specific immunoresponse. Spanish Group of the European Community Respiratory Health Survey. Int J Epidemiol 1999; 28: 728–34.

   OpenUrl
5. ↵
   Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002; 325: 411–4.

   OpenUrlAbstract/FREE Full Text
6. ↵
   Akerman M, Valentine-Maher S, Rao M, et al. Allergen sensitivity and asthma severity at an inner city asthma center. J Asthma 2003; 40: 55–62.
7. ↵
   Tunnicliffe WS, Fletcher TJ, Hammond K, et al. Sensitivity and exposure to indoor allergens in adults with differing asthma severity. Eur Respir J 1999; 13: 654–9.

   OpenUrlAbstract
8. ↵
   Williams SG, Schmidt DK, Redd SC, Storms W. Key clinical activities for quality asthma care. Recommendations of the National Asthma Education and Prevention Program. MMWR Recomm Rep 2003; 52: 1–8.

   OpenUrlPubMed
9. ↵
   Lin RY, Williams KD. Hypersensitivity to molds in New York City in adults who have asthma. Allergy Asthma Proc 2003; 24: 13–8.

   OpenUrlPubMed
10. ↵
    Stafford RS, Ma J, Finkelstein SN, Haver K, Cockburn I. National trends in asthma visits and asthma pharmacotherapy, 1978–2002. J Allergy Clin Immunol 2003; 111: 729–35.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    Poon AW, Goodman CS, Rubin RJ. In vitro and skin testing for allergy: comparable clinical utility and costs. Am J Manag Care 1998; 4: 969–85.

    OpenUrl
12. ↵
    Current issues relating to in vitro testing for allergen-specific IgE: a workshop report [editorial]. Ann Allergy Asthma Immunol 1999; 82: 407–12.

    OpenUrl
13. ↵
    Burney P, Malmberg E, Chinn S, Jarvis D, Luczynska C, Lai E. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol 1997; 99: 314–22.

    OpenUrlCrossRefPubMedWeb of Science
14. Janson C, Anto J, Burney P, et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001; 18: 598–611.

    OpenUrlAbstract/FREE Full Text
15. Plaschke P, Janson C, Norrman E, Bjornsson E, Ellbjar S, Jarvholm B. Association between atopic sensitization and asthma and bronchial hyperresponsiveness in Swedish adults: pets, and not mites, are the most important allergens. J Allergy Clin Immunol 1999; 104: 58–65.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    Boezen HM, Postma DS, Schouten JP, Kerstjens HA, Rijcken B. PEF variability, bronchial responsiveness and their relation to allergy markers in a random population (20–70 yr). Am J Respir Crit Care Med 1996; 154: 30–5.

    OpenUrlPubMedWeb of Science
17. ↵
    Hamilton RG, Adkinson NF Jr. 23. Clinical laboratory assessment of IgE-dependent hypersensitivity. J Allergy Clin Immunol 2003; 111(2 Suppl): S687–701.
18. ↵
    Wu AW, Young Y, Skinner EA, et al. Quality of care and outcomes of adults with asthma treated by specialists and generalists in managed care. Arch Intern Med 2001; 161: 2554–60.

    OpenUrlCrossRefPubMedWeb of Science